Skip to content

HORIZON

TBVAC-HORIZON

Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity

Programme
Horizon Europe
Started
Ends
Duration
48 months
Total cost
EUR 7,110,650
EU contribution
EUR 6,183,822
Participants
19 from 8 countries
Topic
HORIZON_HORIZON-HLTH-2022-DISEASE-06-03-two-stage
Grant agreement
101080309

Coordinated by Stichting Tuberculosis Vaccine Initiative (NLNetherlands).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
Stichting Tuberculosis Vaccine InitiativeNLNetherlandsCoordinatorEUR 500,000PIC (1.00)
Universitat BaselCHSwitzerlandAssociated partnerEUR 0known name (0.95)
Vaccine Formulation Institute(ch)ltdCHSwitzerlandAssociated partnerEUR 0PIC (1.00)
Universitaet UlmDEGermanyParticipantEUR 497,500PIC (1.00)
Statens Serum InstitutDKDenmarkParticipantEUR 500,000known name (0.95)
Cz Vaccines S.A.ESSpainParticipantEUR 500,000PIC (1.00)
Universidad de ZaragozaESSpainParticipantEUR 500,000known name (0.95)
Centre National de la Recherche Scientifique CnrsFRFranceParticipantEUR 949,991known name (0.95)
Institut PasteurFRFranceParticipantEUR 497,500PIC (1.00)
Institut Pasteur de Lille FondationFRFranceParticipantEUR 491,000PIC (1.00)
Universite de ToulouseFRFranceThird partyNot statedknown name (0.95)
Department of HealthGBUnited KingdomAssociated partnerEUR 0known name (0.95)
London School of Hygiene and Tropical Medicine Royal CharterGBUnited KingdomAssociated partnerEUR 0PIC (1.00)
Medicines and Healthcare Products Regulatory AgencyGBUnited KingdomAssociated partnerEUR 0PIC (1.00)
The Chancellor, Masters and Scholars of the University of OxfordGBUnited KingdomAssociated partnerEUR 0PIC (1.00)
University of LeicesterGBUnited KingdomAssociated partnerEUR 0known name (0.95)
Istituto Nazionale Per le Malattie Infettive Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere ScientificoITItalyParticipantEUR 350,250VAT number (0.97)
Academisch Ziekenhuis LeidenNLNetherlandsParticipantEUR 497,581PIC (1.00)
Stichting Biomedical Primate Research CenterNLNetherlandsParticipantEUR 900,000PIC (1.00)

Changes of the consortium

First seen on with 19 participants from 8 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.